Apples to Oranges For whatever reason there seems to be a significantly higher number of ongoing studies with psilocybin as compared to MBio which seems almost lone wolf in trials using LSD. As is now being discussed on ceo what are the implications of this. Imho not much.
With psilocybin the focus has been on ingesting enough to create a hallucinogenic effect which requires psychiatric/psychological intervention before, during and after the treatment. Even researchers are being cautious because while potentially a very significant treatment option, it would be prohibitively expensive and time consuming at least as currently projected ....notwithstanding this is also very early stage.
Whether anything revolving around patents for MBio is possible ....it may not be necessary, as getting approval to carry out studies is still restrictive in many if not most jurisdictions ....particularly the US. It's certainly advantageous for MBio to be out of the gate early and establishing some positive results.
GLTA!!!